Description
Updated settlement calendar for the acquisition window takeover of PHARMAIDS PHARMACEUTICALS LIMITED with revised obligation download and settlement dates.
Summary
BSE has revised the settlement schedule for the takeover offer of PHARMAIDS PHARMACEUTICALS LIMITED. The acquisition window was conducted from August 4-18, 2025, with updated obligation download and settlement dates now set for August 22 and 25, 2025 respectively.
Key Points
- Settlement No. 2025067 for PHARMAIDS PHARMACEUTICALS LIMITED takeover
- Bid period: August 4-18, 2025 (completed)
- Demat shares must be delivered through Early Pay-in mechanism only
- Market type “Takeover” and settlement no. 2025035 to be used in depository systems
- Members can refer to MBRSTD_OTB_CM_mmm_SettNo file for client-wise stamp duty charges
Regulatory Changes
No new regulatory changes introduced - this is a schedule revision for an existing takeover process.
Compliance Requirements
- Members/Custodians must use Early Pay-in of Shares mechanism for demat share delivery
- Proper settlement type and number must be specified in depository systems
- Reference to existing guidelines from Notice No.20200528-32 dated May 28, 2020
- Contact ICCL Help Desk for clarifications at 022-69158590/45720490/45720690
Important Dates
- Bid Period: August 4-18, 2025 (completed)
- Revised Obligation Download: August 22, 2025
- Revised Settlement Date: August 25, 2025
Impact Assessment
Medium impact limited to participants in PHARMAIDS PHARMACEUTICALS takeover. The revision provides updated timeline for settlement obligations and payments. Members and custodians involved in this specific takeover need to adjust their settlement processes according to the new dates.
Impact Justification
Company-specific takeover settlement revision affecting trading participants and custodians